Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

All GLG News Analyses Filed Under: Business of Medicine

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

Genentech and Dako Collaborate To Increase Herceptin Use In Gastric Cancer

August 18, 2009

GLG Expert Contributor

Dako enters collaboration with Genentech on diagnostic tests for patients with stomach cancer | www.pipelinereview.com

Phase III data presented at ASCO in 2009 demonstrated a benefit for patients with HER-2 overexpressing gastric cancer who received Herceptin.  Dako, the developer of the HercepTest and Genetech, the manufacturer of Herceptin, have joined forces to increase HER2 testing and Herceptin utilization.

SUN PHARMA GETS US NOD FOR 2 GENERIC Drugs

August 18, 2009

GLG Expert Contributor

Sun Pharma gets US nod for two generic drugs | economictimes.indiatimes.com

It will definetly boost the share price if SUN Pharma in India and it help to increse the share of sales in US marketing

Global Pharma Business set for a complete Make Over!!!!

August 18, 2009

GLG Expert Contributor

Big pharma companies join outsourcing queue | www.business-standard.com

Pharma - Healthcare cost - People - Politics - Government - Power. This is the long link & effect of pharma on global stage !!! Every Government especially US is crying one chores "Cut Healthcare Cost" With India having the largest US FDA approved set of manufacturing facilities outside US, India becomes a natural partner. As the article suggests, outsourcing deals will get bigger & broader. Pharma will soon see the revolution seen couple of years back in India IT industry!!! 

Is Aurobindo trying to do a Satyam on its investors!!!

August 18, 2009

GLG Expert Contributor

Aurobindo Pharma to Buy Trident Life for About $27.85 Million | online.wsj.com

With memories of Satyam Infotech $ 2 billion scam fresh in everyone's mind, it is a very wrong move by Aurobindo. During consultations investors had asked me this very question "Corporate Governance" My reply was, this is one thing difficult to predict. Aurobindo which has built it's trust over decades should stay away from such moves. Specially when the target company or the company to be bough belongs to your son!!! 

2 generic drugs - Imitrex and Eloxatin

August 16, 2009

GLG Expert Contributor

Sun Pharma gets US nod for two generic drugs | economictimes.indiatimes.com

I do not have a problem with a generic-like Imitrex. I do for Eloxatin. Generics can be up to 20% off, so for migraine med, that is more acceptable than a cancer treatment.

we already have sumatriptan

August 14, 2009

GLG Expert Contributor

Orchid gets USFDA approval for migraine drug | economictimes.indiatimes.com

I read the article re 'Orchid gets USFDA approval for migraine drug'. This refers to Sumatriptan, 25mg, 50mg and 100mg.

Have You Looked at Clouds from Both Sides Now?

August 14, 2009

GLG Expert Contributor

Making the 'Big Switch' to Cloud Computing | www.modernhealthcare.com

Are we at an inflection point in the history of computing? Are we entering a period of inevitable conversion from mainframe, client server and local network technologies, overwhelmingly the dominant models in clinical health care computing today, to the next generation of offsite, remotely hosted ad managed services via the "World Wide Computer" (otherwise known as 'cloud computing')?

Indian set to become the HUB of Clinical Research

August 9, 2009

GLG Expert Contributor

India a preferred destination for clinical trials: Study- Biotech-Healthcare / Biotech-News By Industry-News-The Economic Times | economictimes.indiatimes.com

The Report says it all !!! Cost of RnD , Clinical trials and related activities required for drug development have escalated beyond justifiable levels in developed nations. In order to continuously innovate & keep the drug pipeline humming, a shift in process was required and India was the answer!!! With its inherent cost advantage & pool of highly skilled & qualified people it's a safe bet.   

Aurobindo continues to strenghten its presence in US Markets!!

August 9, 2009

GLG Expert Contributor

Aurobindo gets FDA nod for muscle relaxant | www.business-standard.com

Aurobindo is one of the few Indian company's which has understood the US regulatory really well. It has the largest number of US FDA approved manufacturing facilities. And to complement that it has the highest number of products approved by USFDA. This particular new addition to the family is all set to contribute significantly to their bottom line. 

How Accountable Care Organizations may Provide the Bridge to a Bipartisan Bill

August 7, 2009

GLG Expert Contributor

Health Policy is Carved out at Table for 6 | www.nytimes.com

It would seem that at least until September 15 (the deadline imposed by Max Baucus, D-Montana, and Chairman of the Senate Finance Committee when there will be a vote on the legislation crafted by that time with or without Republican support), national healthcare reform is being held hostage by a "Gang of Six" U.S. Senators--sometimes known in recent military lingo as the "Coalition of the Willing". The other 529 members of Congress appear to be mere pawns in the process until that fateful day

Previous Page : 234567891011Next61 to 70 of 1031

Subscribe to Updates

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines

Leading institutions connect with members of the Healthcare councils through GLG

Get Intelligently Connected
with the world's leading experts

GLG's 850+ Clients Include:

More than 70% of the world's leading
mutual funds
15 of the leading 20
global banks
7 of the leading 10
global private equity firms
5 of the leading 10
AmLaw firms
Fortune 500® Companies
in nearly every industry sector, including pharmaceuticals, insurance, chemicals, energy and computer software